Patient Power®
Get Email Alerts!
Health Topics
View all Health Topics >

Expert Perspective: Justice Ginsburg's Pancreatic Cancer

Recorded on 2/5/2009

PROGRAM DETAILS:

U.S. Supreme Court Justice Ruth Bader Ginsburg, 75, one of only two women to ever serve on the U.S. Supreme Court, had surgery Thursday, Feb. 4, 2009, for pancreatic cancer. While the survival statistics after diagnosis of pancreatic cancer are bleak, for the patients who are able to undergo surgery and recover, there is more hope. Dr. Sunil Hingorani, a leading pancreatic cancer specialist, at the Seattle Cancer Care Alliance (SCCA) and a researcher at the Fred Hutchinson Cancer Research Center, joined Andrew for this special “breaking news” program to share his perspective on Justice Gingsburg's situation and the latest in pancreatic cancer in general.

Dr. Hingorani begins by talking about the diagnosis and treatment of pancreatic cancer. He speaks about the difficulty in diagnosis because pancreatic cancer symptoms tend to be vague and go easily unnoticed. Dr. Hingorani talks about treatment of this type of cancer, specifically through a surgery called the Whipple Procedure. He goes on to talk about the prospects of long-term survival and chemotherapy after surgery.

Dr. Hingorani shares information about the risk factors associated with pancreatic cancer, and touches on the familial connection. If you have recently heard about this type of cancer in the news, this program provides an expert perspective into the media attention.

Get Email Updates:

Get updated automatically when new content about Pancreatic Cancer has been posted.
Privacy Policy
Pancreatic Cancer
EXPERTS & GUESTS:
Sunil Hingorani,  M.D., Ph.D. Sunil Hingorani, M.D., Ph.D.
Medical Oncologist, Seattle Cancer Care Alliance
Dr. Hingorani is Director of the Pancreas Cancer Specialty Clinic at the Seattle Cancer Care Alliance and Fred Hutchinson Cancer Research Center. He also runs a research laboratory dedicated to uncovering mechanisms of pancreatic cancer formation and developing new early detection and treatment strategies. He led the development of the first mouse model of pancreatic cancer – a study of... more >

TRANSCRIPT:

RELATED LINKS: